EVOGENE LTDNARY SHARES
EVOGENE LTDNARY SHARES
Share · IL0011050551 · EVGN (XNAS)
Overview Financial Indicators
1,10 USD
-0,45 % -0,005 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 19:55

Current Prices from EVOGENE LTDNARY SHARES

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
EVGN
USD
06.06.2025 19:55
1,10 USD
1,11 USD
-0,45 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,92 % -3,51 % -22,54 % -23,08 % -83,82 % -90,91 %

Company Profile for EVOGENE LTDNARY SHARES Share

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Company Data

Name EVOGENE LTDNARY SHARES
Company Evogene Ltd.
Symbol EVGN
Website https://www.evogene.com
Primary Exchange XNAS NASDAQ
ISIN IL0011050551
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Ofer Haviv CPA
Country Israel
Currency USD
Employees 0,1 T
Address 13 Gad Feinstein Street, 7414002 Rehovot
IPO Date 2010-10-15

Stock Splits

Date Split
25.07.2024 1:10
19.11.2013 1:2

Ticker Symbols

Name Symbol
NASDAQ EVGN

More Shares

Investors who EVOGENE LTDNARY SHARES hold also have the following shares in their portfolio:
BYND Cannasoft Enterprises Inc. - Common Stock
BYND Cannasoft Enterprises Inc. - Common Stock Share
TC ZIRAAT BK 24/29 MTN
TC ZIRAAT BK 24/29 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025